×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: pfizer | cancer | exubera

EU: Pfizer Must Give Exubera Cancer Warning

Tuesday, 17 June 2008 12:35 PM

LONDON, June 17 (Reuters) - The European Medicines Agency said on Tuesday that information about lung cancer should be added to the label for Pfizer Inc's inhaled insulin drug Exubera, due to increased cases in patients taking the product.

The move is no great surprise, since Pfizer and its partner Nektar Therapeutics announced in April that clinical trials had revealed a increased cancer rate.

That revelation dealt a final blow to Exubera, which had held the promise of letting diabetics avoid needles but proved a commercial flop. The European agency said Exubera was not expected to be available in the European Union after September 2008.

© 2022 Newsmax. All rights reserved.


Companies
LONDON, June 17 (Reuters) - The European Medicines Agency said on Tuesday that information about lung cancer should be added to the label for Pfizer Inc's inhaled insulin drug Exubera, due to increased cases in patients taking the product.The move is no great surprise,...
pfizer,cancer,exubera
105
2008-35-17
Tuesday, 17 June 2008 12:35 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved